Company Filing History:
Years Active: 2005
Title: **The Innovative Contributions of Dina Blasberger in Pharmaceutical Chemistry**
Introduction
Dina Blasberger, a talented inventor based in Raanana, Israel, has made significant strides in the field of pharmaceutical chemistry. Her work has led to the development of novel polymorphs of valacyclovir hydrochloride, contributing to the advancement of medications based on this compound. With a total of two patents to her name, Dina's contributions are noteworthy in the pharmaceutical industry.
Latest Patents
Dina's latest patents encompass two significant inventions:
1. **Crystalline Forms of Valacyclovir Hydrochloride**: This patent covers novel polymorphs and pseudopolymorphs of valacyclovir hydrochloride, along with pharmaceutical compositions that include these new forms. The patent also describes methods for synthesizing these novel polymorphs and pseudopolymorphs, specifically valacyclovir hydrochloride monohydrate and valacyclovir hydrochloride dihydrate.
2. **Synthesis and Purification of Valacyclovir**: In her second patent, Dina focuses on a method for creating a protected form of valacyclovir. This involves using N-tert-butoxycarbonyl-L-valine and coupling it with acyclovir via a coupling agent. The process includes deprotecting the protected valacyclovir to yield pure valacyclovir or its pharmaceutically acceptable salts, as well as methods for achieving a pure form of valacyclovir in pharmaceutical formulations.
Career Highlights
Dina Blasberger is affiliated with Teva Pharmaceutical Industries Limited, where she applies her expertise in pharmaceutical chemistry to develop innovative drug formulations. Her career has been marked by significant research aimed at improving the efficacy and stability of pharmaceutical products.
Collaborations
Working alongside fellow professionals such as Marina Etinger and Michael Yuzefovich, Dina has fostered a collaborative environment that promotes the exchange of ideas and innovation within the research community. Together, they strive to advance the understanding and utilization of valacyclovir in various therapeutic contexts.
Conclusion
Dina Blasberger stands out as a dedicated inventor whose work has the potential to significantly impact the field of pharmaceuticals. Her innovative patents not only highlight her expertise but also underscore the importance of collaboration in driving advancements in drug development. As the pharmaceutical industry continues to evolve, contributions from inventors like Dina are critical in providing effective and safe medicinal solutions.